Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-009-1206-3PMID 20033812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

  2009cited by this paper
• Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.

  2008cited by this paper
• Adjuvant Treatment of Colorectal Cancer

  2007cited by this paper
• Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.

  2007cited by this paper
• Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

  2007cited by this paper
• Microsatellite instability in colorectal cancer

  2006cited by this paper
• Systematic review of microsatellite instability and colorectal cancer prognosis.

  2005cited by this paper
• P53 abnormalities and outcomes in colorectal cancer: a systematic review

  2005cited by this paper
• High Frequency of Microsatellite Instability in Intestinal-type Gastric Cancer in Korean Patients

  2005cited by this paper
• Two colons‐two cancers: Paradigm shift and clinical implications

  2004cited by this paper
• Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.

  2004cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003influential reference
• Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer.

  2002cited by this paper
• Emerging pathways in colorectal-cancer development.

  2002cited by this paper
• DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.

  2002cited by this paper
• Emerging concepts in colorectal neoplasia.

  2002cited by this paper
• Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

  2002cited by this paper
• The results of colorectal cancer treatment by p53 status

  2001cited by this paper
• Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.

  2001cited by this paper
• Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

  2000cited by this paper
• The Role of Mismatched Nucleotides in Activating the hMSH2-hMSH6 Molecular Switch*

  2000cited by this paper
• Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.

  2000cited by this paper
• A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

  1999cited by this paper
• Morphology of sporadic colorectal cancer with DNA replication errors

  1998cited by this paper
• Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

  1998cited by this paper
• In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

  1997cited by this paper
• hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

  1997cited by this paper
• The role of DNA mismatch repair in platinum drug resistance.

  1996cited by this paper
• Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.

  1996cited by this paper
• Loss of DNA mismatch repair in acquired resistance to cisplatin.

  1996cited by this paper
• Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

  1993cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper
• Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

  1993cited by this paper
• Clues to the pathogenesis of familial colorectal cancer.

  1993cited by this paper
• An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

  1993cited by this paper

• A narrative review of prognostic indices in the evaluation of gastrointestinal cancers

  2023cites this paper
• Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway.

  2023cites this paper
• Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review).

  2023cites this paper
• Synchronous Recto-Sigmoid Colorectal Carcinomas With Microsatellite Instability and an Activating PIK3CA Mutation

  2022cites this paper
• Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer.

  2021cites this paper
• Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis

  2021cites this paper
• A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing

  2021cites this paper
• Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

  2021cites this paper
• Finding the hot spot: identifying immune sensitive gastrointestinal tumors.

  2020influential citation
• Chemotherapeutic effects of MEK kinase inhibitor and BRAF kinase inhibitor on KRAS-mutated human colon cancer cell lines with different microsatellite instability

  2020cites this paper
• Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

  2020cites this paper
• Adjuvant Chemotherapy in Microsatellite Instability–High Gastric Cancer

  2020cites this paper
• Adjuvant chemotherapy in resected colon cancer: When, how and how long?

  2019cites this paper
• Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX

  2019cites this paper
• Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma

  2018cites this paper
• Etude du rôle du corégulateur transcriptionnel RIP140 dans le contrôle de l'instabilité microsatellitaire des cancers colorectaux héréditaires

  2017cites this paper
• Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers

  2017cites this paper
• Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer

  2017cites this paper
• Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)

  2017cites this paper
• Prognostic factors in sporadic colon cancer with high-level microsatellite instability.

  2016cites this paper
• The evolving role of microsatellite instability in colorectal cancer: A review.

  2016cites this paper
• MOLECULAR GENETIC CHARACTERISTICS OF GASTRIC CANCERS FROM THE SURGEON’S POINT OF VIEW

  2016cites this paper
• The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis

  2015cites this paper
• Deficient mismatch repair: Read all about it (Review)

  2015cites this paper
• Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer

  2015cites this paper
• Distinctive Tumor Biology of MSI-High Colorectal Cancer

  2015cites this paper
• Implications of mismatch repair-deficient status on management of early stage colorectal cancer.

  2015cites this paper
• Chemotherapy for Stage II Colon Cancer

  2015cites this paper
• Novel and Emerging Targeted Therapies of Colorectal Cancer.

  2015cites this paper
• Should mismatch repair status be determined in all stage II and III colon cancer patients

  2014cites this paper
• Prognostic Impact of Deficient DNA Mismatch Repair and KRAS and BRAFV600E Mutations in Patients with Lymph-Node-Positive Colon Cancer

  2014cites this paper
• A DJUVANT THERAPY FOR COLORECTAL CANCER

  2014cites this paper
• Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAFV600E in Patients with Lymph Node-Positive Colon Cancer.

  2014cites this paper
• Clinicopathologic Impacts of Poorly Differentiated Cluster-Based Grading System in Colorectal Carcinoma

  2014influential citation
• Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

  2014cites this paper
• Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?

  2014cites this paper
• Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy

  2014cites this paper
• Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review

  2014cites this paper
• Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

  2014cites this paper
• The prognostic role of microsatellite instability, codon‐specific KRAS, and BRAF mutations in colon cancer

  2014cites this paper
• Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.

  2013cites this paper
• Role of microsatellite instability in the management of colorectal cancers.

  2013cites this paper
• Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases

  2013cites this paper
• Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer

  2013cites this paper
• A multi‐center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

  2013cites this paper
• Chemotherapy of MMR-deficient colorectal cancer

  2013cites this paper
• Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

  2013cites this paper
• The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

  2013cites this paper
• Use of molecular biomarkers to inform adjuvant therapy for colon cancer.

  2013cites this paper
• Biomarkers and targeted therapeutics in colorectal cancer.

  2013cites this paper
• Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

  2013cites this paper
• Individualized therapy for metastatic colorectal cancer

  2013cites this paper
• A Study of Cancer Heterogeneity: From Genetic Instability to Epigenetic Diversity in Colorectal Cancer

  2013cites this paper
• Therapeutic implications of DNA mismatch repair in adjuvant colorectal cancer chemotherapy

  2013cites this paper
• L’instabilité microsatellite tumorale est un facteur prédictif du bénéfice d’une chimiothérapie adjuvante par 5 fluorouracile après résection d’un cancer du côlon

  2013cites this paper
• Optimal Treatment Strategies for Localized and Advanced Microsatellite Instability–High Colorectal Cancer

  2012cites this paper
• Clinicopathologic features and prognostic analysis of MSI-high colon cancer

  2012influential citation
• Oncologic Management of Hereditary Colorectal Cancer

  2012cites this paper
• Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells

  2012cites this paper
• Microsatellite Instability and Outcomes in Colorectal Cancer

  2012cites this paper
• Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas

  2012cites this paper
• DNA repair mechanisms in colorectal carcinogenesis.

  2012cites this paper
• How Many Diseases Are Colorectal Cancer?

  2012cites this paper
• Gene expression variations in microsatellite stable and unstable colon cancer cells.

  2012cites this paper
• DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy

  2011cites this paper
• Adjuvant chemotherapy in colon carcinoma stages II and III

  2011cites this paper
• Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies

  2011cites this paper
• Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer.

  2011cites this paper
• Drug therapy for hereditary cancers

  2011cites this paper
• Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine

  2011cites this paper
• Kolonkarzinom: Aktueller Stand der multimodalen Therapie

  2011cites this paper
• Molecular Profiling of Colon Tumors: The Search for Clinically Relevant Biomarkers of Progression, Prognosis, Therapeutics, and Predisposition

  2011cites this paper
• Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications

  2011influential citation
• Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

  2011cites this paper
• Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer.

  2011cites this paper
• Microsatellite instability in the management of colorectal cancer

  2011cites this paper
• Predictive Biomarkers and Personalized Medicine DefectiveMismatchRepair Status asaPrognosticBiomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

  2011cites this paper
• DNA repair pathways and their implication in cancer treatment

  2010cites this paper
• Clinical genetics of hereditary colorectal cancer.

  2010cites this paper
• Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

  2010cites this paper
• Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?

  2010cites this paper
• Oncotargets and Therapy Dovepress Clinical Course and Outcome of Patients with High-level Microsatellite Instability Cancers in a Real-life Setting: a Retrospective Analysis

  year unknowncites this paper